Connect Biopharma Holdings Ltd. (Nasdaq: CNTB), a clinical-stage biopharmaceutical company focused on inflammatory diseases, will participate in two upcoming investor conferences. The company will present at the Cantor Global Healthcare Conference on September 3rd, 2025, at 3:20 p.m. ET, and at the H.C. Wainwright 27th Annual Global Investment Conference on September 8th, 2025, at 9:30 a.m. ET. Both presentations will be in the format of a fireside chat.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Connect Biopharma Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9518546-en) on August 27, 2025, and is solely responsible for the information contained therein.